MARGRETT MCPHERSON: Open Payments
NPI 1457990889 · POCAHONTAS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 34 payments from 11 companies in 2025. Trend: 2023 $671 · 2024 $749 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $217 |
| Amgen Inc. | 6 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Lundbeck LLC | 2 | $62 |
| Phathom Pharmaceuticals, Inc. | 5 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Exact Sciences Corporation | 2 | $30 |
| Novo Nordisk Inc | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
Products named: BREZTRI, REXULTI, OTEZLA, VOQUEZNA, XIFAXAN, CAPLYTA, AIRSUPRA, GEMTESA.
Industry payments across AR — which companies pay providers there.
